Literature DB >> 3307954

Retarded recovery of functional T cell frequencies in T cell-depleted bone marrow transplant recipients.

J P Daley1, M K Rozans, B R Smith, S J Burakoff, J M Rappeport, R A Miller.   

Abstract

We have studied the effect of removing donor T cells by treatment with the monoclonal antibody Leu-1 and complement before marrow transplantation on the regeneration of functionally competent T lymphocytes in the blood at selected times after transplant. Using sensitive limiting-dilution methods that allow us to enumerate helper, cytotoxic, and proliferating T lymphocyte precursors, we report that regeneration of a functional T cell compartment is more severely impaired for the first 180 days after transplantation in those patients given T cell-depleted bone marrow than in recipients of untreated marrow. After this first 6 months, however, patients given T cell-depleted bone marrow had blood T cell frequencies comparable to those observed in patients given untreated marrow. Diminished frequencies of reactive T cells in recipients of depleted marrow could leave them more susceptible to infection or to the recurrence of neoplastic cells.

Entities:  

Mesh:

Year:  1987        PMID: 3307954

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Onder Alpdogan; Stephanie J Muriglan; Jeffrey M Eng; Lucy M Willis; Andrew S Greenberg; Barry J Kappel; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

2.  Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation.

Authors:  H Kook; F Goldman; R Giller; N Goeken; C Peters; M Comito; S Rumelhart; M Holida; N Lee; M Trigg
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

3.  Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ+/CD19+-depleted grafts.

Authors:  Javid Gaziev; Antonella Isgrò; Pietro Sodani; Katia Paciaroni; Gioia De Angelis; Marco Marziali; Michela Ribersani; Cecilia Alfieri; Alessandro Lanti; Tiziana Galluccio; Gaspare Adorno; Marco Andreani
Journal:  Blood Adv       Date:  2018-02-13

4.  Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.

Authors:  Benjamin R Oshrine; Yimei Li; David T Teachey; Jennifer Heimall; David M Barrett; Nancy Bunin
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-11       Impact factor: 5.742

5.  Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

Authors:  Stefan O Ciurea; Victor Mulanovich; Rima M Saliba; Ulas D Bayraktar; Ying Jiang; Roland Bassett; Sa A Wang; Marina Konopleva; Marcelo Fernandez-Vina; Nivia Montes; Doyle Bosque; Julianne Chen; Gabriela Rondon; Gheath Alatrash; Amin Alousi; Qaiser Bashir; Martin Korbling; Muzaffar Qazilbash; Simrit Parmar; Elizabeth Shpall; Yago Nieto; Chitra Hosing; Partow Kebriaei; Issa Khouri; Uday Popat; Marcos de Lima; Richard E Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-11       Impact factor: 5.742

6.  Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study.

Authors:  Emilia Salzmann-Manrique; Melanie Bremm; Sabine Huenecke; Milena Stech; Andreas Orth; Matthias Eyrich; Ansgar Schulz; Ruth Esser; Thomas Klingebiel; Peter Bader; Eva Herrmann; Ulrike Koehl
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

7.  Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.

Authors:  R E Donahue; S W Kessler; D Bodine; K McDonagh; C Dunbar; S Goodman; B Agricola; E Byrne; M Raffeld; R Moen
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.